Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters









Database
Type of study
Language
Publication year range
1.
Primary aldosteronism-not just about potassium and blood pressure.
Toh, T H; Tong, C V; Chong, H C.
QJM ; 110(3): 175-177, 2017 Mar 01.
Article in English | MEDLINE | ID: mdl-28069910

Subject(s)
Hyperaldosteronism/complications , Hyperaldosteronism/diagnosis , Hypertension/etiology , Potassium/blood , Adenoma/complications , Adenoma/surgery , Adrenal Gland Neoplasms/complications , Adrenal Gland Neoplasms/surgery , Adrenalectomy/methods , Adult , Blood Pressure/physiology , Female , Humans , Hyperaldosteronism/blood , Hyperaldosteronism/surgery , Hypocalcemia/etiology , Hypokalemia/etiology , Magnesium/blood
2.
Choriocarcinoma as a cause of hyperthyroidism.
Tong, C V; Chai, W L.
QJM ; 110(3): 187, 2017 Mar 01.
Article in English | MEDLINE | ID: mdl-28011852
3.
Denosumab as a long-term palliative therapy in parathyroid carcinoma.
Tong, C V; Loh, L T; Hussein, Z.
QJM ; 110(1): 55, 2017 01.
Article in English | MEDLINE | ID: mdl-28011854

Subject(s)
Denosumab , Parathyroid Neoplasms , Antibodies, Monoclonal, Humanized , Bone Density Conservation Agents , Humans , Hypercalcemia , Palliative Care
4.
Response to "Is denosumab a long-term option for the treatment of parathyroid carcinoma?".
Tong, C V; Hussein, Z.
QJM ; 109(4): 289, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26803152

Subject(s)
Antibodies, Monoclonal, Humanized/therapeutic use , Hypercalcemia/drug therapy , Paraneoplastic Syndromes/drug therapy , Parathyroid Neoplasms/complications , Female , Humans
5.
Severe hypertriglyceridemia in a nondiabetic treated with low dose insulin infusion.
Tong, C V; Velaiutham, S; Aziz, N A; Lim, S L; Khaw, C H.
Med J Malaysia ; 70(4): 249-50, 2015 Aug.
Article in English | MEDLINE | ID: mdl-26358023

ABSTRACT

We report a case of a 54-year-old man with severe HTG which did not respond to conventional anti lipid therapies. He was treated with intravenous insulin and concurrent dextrose infusions which led to a dramatic reduction in serum triglyceride levels.

6.
Use of denosumab in parathyroid carcinoma with refractory hypercalcemia.
Tong, C V; Hussein, Z; Noor, N Mohd; Mohamad, M; Ng, W F.
QJM ; 108(1): 49-50, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25099611

Subject(s)
Antibodies, Monoclonal, Humanized/therapeutic use , Hypercalcemia/drug therapy , Paraneoplastic Syndromes/drug therapy , Parathyroid Neoplasms/complications , Adult , Calcium/blood , Denosumab , Female , Humans , Hypercalcemia/blood , Hypercalcemia/etiology , Lymphatic Metastasis , Paraneoplastic Syndromes/blood , Paraneoplastic Syndromes/etiology
SEND TO:
Email
Export
Print
RSS
XML
SELECTION OF CITATIONS
SEARCH DETAIL